TLR2 modulates antibodies required for intestinal ischemia/reperfusion-induced damage and inflammation

Journal of Immunology

Volumn 194, Issue 3, 2015, Pages 1190-1198

  Pope, Michael R ^a   Fleming, Sherry D ^a  

^a KANSAS STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA2 GLYCOPROTEIN 1; COMPLEMENT COMPONENT C3; CXCL1 CHEMOKINE; CYCLOOXYGENASE 2; ICOSANOID; IMMUNOGLOBULIN M; INTERLEUKIN 6; MYELOID DIFFERENTIATION FACTOR 88; PROSTAGLANDIN E2; TOLL LIKE RECEPTOR 2; ANTIBODY; COMPLEMENT; CYTOKINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INTESTINE INJURY; INTESTINE ISCHEMIA; MORTALITY; MOUSE; NONHUMAN; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; TISSUE INJURY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; BLOOD; DISEASE MODEL; GENETICS; IMMUNOLOGY; INFLAMMATION; INTESTINE; INTESTINE MUCOSA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY;

ANIMALS; ANTIBODIES; BETA 2-GLYCOPROTEIN I; COMPLEMENT SYSTEM PROTEINS; CYTOKINES; DISEASE MODELS, ANIMAL; EICOSANOIDS; IMMUNOGLOBULIN M; INFLAMMATION; INTESTINAL MUCOSA; INTESTINES; MICE; MICE, KNOCKOUT; REPERFUSION INJURY; TOLL-LIKE RECEPTOR 2;

EID: 84921482707     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1303124     Document Type: Article

References (61)

1. Aliosmanoglu, I., M. Gul, M. Kapan, Z. Arikanoglu, F. Taskesen, O. Basol, and M. Aldemir. 2013. Risk factors affecting mortality in acute mesenteric ischemia and mortality rates: a single center experience. Int. Surg. 98: 76-81.
2. Yanar, F., O. Agcaoglu, I. S. Sarici, E. Sivrikoz, A. Ucar, H. Yanar, M. Aksoy, and M. Kurtoglu. 2013. Local thrombolytic therapy in acute mesenteric ischemia. World J. Emerg. Surg. 8: 8.
3. Granger, C. B., K. W. Mahaffey, W. D. Weaver, P. Theroux, J. S. Hochman, T. G. Filloon, S. Rollins, T. G. Todaro, J. C. Nicolau, W. Ruzyllo, and P. W. Armstrong, COMMA Investigators. 2003. Pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in myocardial infarction treated with angioplasty (COMMA) trial. Circulation 108: 1184-1190.
4. Rehrig, S., S. D. Fleming, J. Anderson, J. M. Guthridge, J. Rakstang, C. E. McQueen, V. M. Holers, G. C. Tsokos, and T. Shea-Donohue. 2001. Complement inhibitor, complement receptor 1-related gene/protein y-Ig attenuates intestinal damage after the onset of mesenteric ischemia/reperfusion injury in mice. J. Immunol. 167: 5921-5927.
5. Zimmerman, B. J., and D. N. Granger. 1994. Mechanisms of reperfusion injury. Am. J. Med. Sci. 307: 284-292.
6. Moses, T., L. Wagner, and S. D. Fleming. 2009. TLR4-mediated Cox-2 expression increases intestinal ischemia/reperfusion-induced damage. J. Leukoc. Biol. 86: 971-980.
7. Fleming, S. D. 2006. Natural antibodies, autoantibodies and complement activation in tissue injury. Autoimmunity 39: 379-386.
8. Williams, J. P., T. T. V. Pechet, M. R. Weiser, R. Reid, L. Kobzik, F. D. Moore, Jr., M. C. Carroll, and H. B. Hechtman. 1999. Intestinal reperfusion injury is mediated by IgM and complement. J. Appl. Physiol. 86: 938-942.
9. Zhang, M., W. G. Austen, Jr., I. Chiu, E. M. Alicot, R. Hung, M. Ma, N. Verna, M. Xu, H. B. Hechtman, F. D. Moore, Jr., and M. C. Carroll. 2004. Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury. Proc. Natl. Acad. Sci. USA 101: 3886-3891.
10. Fleming, S. D., R. P. Egan, C. Chai, G. Girardi, V. M. Holers, J. Salmon, M. Monestier, and G. C. Tsokos. 2004. Anti-phospholipid antibodies restore mesenteric ischemia/reperfusion-induced injury in complement receptor 2/complement receptor 1-deficient mice. J. Immunol. 173: 7055-7061.
11. Zhang, M., and M. C. Carroll. 2007. Natural antibody mediated innate autoimmune response. Mol. Immunol. 44: 103-110.
12. -/-) mice. Autoimmunity 40: 208-216.
13. Kulik, L., S. D. Fleming, C. Moratz, J. W. Reuter, A. Novikov, K. Chen, K. A. Andrews, A. Markaryan, R. J. Quigg, G. J. Silverman, et al. 2009. Pathogenic natural antibodies recognizing annexin IV are required to develop intestinal ischemia-reperfusion injury. J. Immunol. 182: 5363-5373.
14. Pope, M. R., S. M. Hoffman, S. Tomlinson, and S. D. Fleming. 2010. Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol. Immunol. 48: 356-364.
15. Takeuchi, O., K. Hoshino, T. Kawai, H. Sanjo, H. Takada, T. Ogawa, K. Takeda, and S. Akira. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive bacterial cell wall components. Immunity 11: 443-451.
16. Rakoff-Nahoum, S., J. Paglino, F. Eslami-Varzaneh, S. Edberg, and R. Medzhitov. 2004. Recognition of commensal microflora by Toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241.
17. Mollen, K. P., R. J. Anand, A. Tsung, J. M. Prince, R. M. Levy, and T. R. Billiar. 2006. Emerging paradigm: Toll-like receptor 4-sentinel for the detection of tissue damage. Shock 26: 430-437.
18. Takeishi, Y., and I. Kubota. 2009. Role of Toll-like receptor mediated signaling pathway in ischemic heart. Front Biosci (Landmark Ed) 14: 2553-2558.
19. Wu, H., G. Chen, K. R. Wyburn, J. Yin, P. Bertolino, J. M. Eris, S. I. Alexander, A. F. Sharland, and S. J. Chadban. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117: 2847-2859.
20. Li, C., T. Ha, J. Kelley, X. Gao, Y. Qiu, R. L. Kao, W. Browder, and D. L. Williams. 2004. Modulating Toll-like receptor mediated signaling by (1 - >3)-beta-D-glucan rapidly induces cardioprotection. Cardiovasc. Res. 61: 538-547.
21. Gao, Y., X. Fang, Y. Tong, Y. Liu, and B. Zhang. 2009. TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. Biomed. Pharmacother. 63: 442-450.
22. Victoni, T., F. R. Coelho, A. L. Soares, A. de Freitas, T. Secher, R. Guabiraba, F. Erard, R. M. de Oliveira-Filho, B. B. Vargaftig, G. Lauvaux, et al. 2010. Local and remote tissue injury upon intestinal ischemia and reperfusion depends on the TLR/MyD88 signaling pathway. Med. Microbiol. Immunol. 199: 35-42.
23. Yang, Q. W., J. C. Li, F. L. Lu, A. Q. Wen, J. Xiang, L. L. Zhang, Z. Y. Huang, and J. Z. Wang. 2008. Upregulated expression of Toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J. Cereb. Blood Flow Metab. 28: 1588-1596.
24. Hua, F., J. Wang, I. Sayeed, T. Ishrat, F. Atif, and D. G. Stein. 2009. The TRIF-dependent signaling pathway is not required for acute cerebral ischemia/reperfusion injury in mice. Biochem. Biophys. Res. Commun. 390: 678-683.
25. Shigeoka, A. A., T. D. Holscher, A. J. King, F. W. Hall, W. B. Kiosses, P. S. Tobias, N. Mackman, and D. B. McKay. 2007. TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J. Immunol. 178: 6252-6258.
26. Watanabe, T., T. Tanigawa, A. Kobata, S. Takeda, Y. Nadatani, K. Otani, H. Yamagami, M. Shiba, K. Tominaga, Y. Fujiwara, and T. Arakawa. 2014. Tolllike receptor 2 mediates ischemia-reperfusion injury of the small intestine in adult mice. PLoS One 9: e110441.
27. Slone, E. A., M. R. Pope, M. Roth, R. Welti, and S. D. Fleming. 2012. TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage. Am. J. Clin. Exp. Immunol. 1: 124-135.
28. Chiu, C.-J., A. H. McArdle, R. Brown, H. J. Scott, and F. N. Gurd. 1970. Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal. Arch. Surg. 101: 478-483.
29. Sjogren, R. W., C. Colleton, and T. Shea-Donohue. 1994. Intestinal myoelectric response in two different models of acute enteric inflammation. Am. J. Physiol. 267: G329-G337.
30. Zhao, A., J. F. Urban, Jr., R. M. Anthony, R. Sun, J. Stiltz, N. van Rooijen, T. A. Wynn, W. C. Gause, and T. Shea-Donohue. 2008. Th2 cytokine-induced alterations in intestinal smooth muscle function depend on alternatively activated macrophages. Gastroenterology 135: 217-225, e1.
31. Tomasi, M., Y. Hiromasa, M. R. Pope, S. Gudlur, J. M. Tomich, and S. D. Fleming. 2012. Human β2-glycoprotein I attenuates mouse intestinal ischemia/reperfusion induced injury and inflammation. Mol. Immunol. 52: 207-216.
32. Anderson, J., S. D. Fleming, S. Rehrig, G. C. Tsokos, M. Basta, and T. Shea-Donohue. 2005. Intravenous immunoglobulin attenuates mesenteric ischemia-reperfusion injury. Clin. Immunol. 114: 137-146.
33. Eror, A. T., A. Stojadinovic, B. W. Starnes, S. C. Makrides, G. C. Tsokos, and T. Shea-Donohue. 1999. Antiinflammatory effects of soluble complement receptor type 1 promote rapid recovery of ischemia/reperfusion injury in rat small intestine. Clin. Immunol. 90: 266-275.
34. Fleming, S. D., D. Mastellos, G. Karpel-Massler, T. Shea-Donohue, J. D. Lambris, and G. C. Tsokos. 2003. C5a causes limited, polymorphonuclear cell-independent, mesenteric ischemia/reperfusion-induced injury. Clin. Immunol. 108: 263-273.
35. Fleming, S. D., T. Shea-Donohue, J. M. Guthridge, L. Kulik, T. J. Waldschmidt, M. G. Gipson, G. C. Tsokos, and V. M. Holers. 2002. Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J. Immunol. 169: 2126-2133.
36. Carroll, M. C., and V. M. Holers. 2005. Innate autoimmunity. Adv. Immunol. 86: 137-157.
37. Sparkes, B. L., E. E. Slone, M. Roth, R. Welti, and S. D. Fleming. 2010. Intestinal lipid alterations occur prior to antibody-induced prostaglandin E2 production in a mouse model of ischemia/reperfusion. Biochim. Biophys. Acta 1801: 517-525.
38. Fleming, S. D., M. R. Pope, S. M. Hoffman, T. Moses, U. Bukovnik, J. M. Tomich, L. M. Wagner, and K. M. Woods. 2010. Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation. J. Immunol. 185: 6168-6178.
39. Aprahamian, C. J., R. G. Lorenz, C. M. Harmon, and R. A. Dimmit. 2008. Tolllike receptor 2 is protective of ischemia-reperfusion-mediated small-bowel injury in a murine model. Pediatr. Crit. Care Med. 9: 105-109.
40. Stringa, P., N. Lausada, D. Romanin, M. Machuca, A. Cabanne, M. Rumbo, and G. Gondolesi. 2012. Defining the nonreturn time for intestinal ischemia reperfusion injury in mice. Transplant. Proc. 44: 1214-1217.
41. Arslan, F., M. B. Smeets, L. A. O'Neill, B. Keogh, P. McGuirk, L. Timmers, C. Tersteeg, I. E. Hoefer, P. A. Doevendans, G. Pasterkamp, and D. P. de Kleijn. 2010. Myocardial ischemia/reperfusion injury is mediated by leukocytic Tolllike receptor-2 and reduced by systemic administration of a novel anti-Toll-like receptor-2 antibody. Circulation 121: 80-90.
42. Favre, J., P. Musette, V. Douin-Echinard, K. Laude, J. P. Henry, J. F. Arnal, C. Thuillez, and V. Richard. 2007. Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction. Arterioscler. Thromb. Vasc. Biol. 27: 1064-1071.
43. Ben Mkaddem, S., E. Pedruzzi, C. Werts, N. Coant, M. Bens, F. Cluzeaud, J. M. Goujon, E. Ogier-Denis, and A. Vandewalle. 2010. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury. Cell Death Differ. 17: 1474-1485.
44. Leemans, J. C., G. Stokman, N. Claessen, K. M. Rouschop, G. J. Teske, C. J. Kirschning, S. Akira, T. van der Poll, J. J. Weening, and S. Florquin. 2005. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115: 2894-2903.
45. Morrison, H., J. Frye, G. Davis-Gorman, J. Funk, P. McDonagh, G. Stahl, and L. Ritter. 2011. The contribution of mannose binding lectin to reperfusion injury after ischemic stroke. Curr. Neurovasc. Res. 8: 52-63.
46. Amura, C. R., B. Renner, T. Lyubchenko, S. Faubel, P. L. Simonian, and J. M. Thurman. 2012. Complement activation and Toll-like receptor-2 signaling contribute to cytokine production after renal ischemia/reperfusion. Mol. Immunol. 52: 249-257.
47. Haas, M. S., E. M. Alicot, F. Schuerpf, I. Chiu, J. Li, F. D. Moore, and M. C. Carroll. 2010. Blockade of self-reactive IgM significantly reduces injury in a murine model of acute myocardial infarction. Cardiovasc. Res. 87: 618-627.
48. Park, P., M. Haas, P. N. Cunningham, L. Bao, J. J. Alexander, and R. J. Quigg. 2002. Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am. J. Physiol. Renal Physiol. 282: F352-F357.
49. Leadbetter, E. A., I. R. Rifkin, A. M. Hohlbaum, B. C. Beaudette, M. J. Shlomchik, and A. Marshak-Rothstein. 2002. Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603-607.
50. Lau, C. M., C. Broughton, A. S. Tabor, S. Akira, R. A. Flavell, M. J. Mamula, S. R. Christensen, M. J. Shlomchik, G. A. Viglianti, I. R. Rifkin, and A. Marshak-Rothstein. 2005. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J. Exp. Med. 202: 1171-1177.
51. Qing, X., M. Pitashny, D. B. Thomas, F. J. Barrat, M. P. Hogarth, and C. Putterman. 2008. Pathogenic anti-DNA antibodies modulate gene expression in mesangial cells: involvement of HMGB1 in anti-DNA antibody-induced renal injury. Immunol. Lett. 121: 61-73.
52. Wen, Z., L. Xu, X. Chen, W. Xu, Z. Yin, X. Gao, and S. Xiong. 2013. Autoantibody induction by DNA-containing immune complexes requires HMGB1 with the TLR2/microRNA-155 pathway. J. Immunol. 190: 5411-5422.
53. Lartigue, A., N. Colliou, S. Calbo, A. François, S. Jacquot, C. Arnoult, F. Tron, D. Gilbert, and P. Musette. 2009. Critical role of TLR2 and TLR4 in autoanti-body production and glomerulonephritis in lpr mutation-induced mouse lupus. J. Immunol. 183: 6207-6216.
54. Pagano, S., N. Satta, D. Werling, V. Offord, P. de Moerloose, E. Charbonney, D. Hochstrasser, P. Roux-Lombard, and N. Vuilleumier. 2012. Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. J. Intern. Med. 272: 344-357.
55. Satta, N., S. Dunoyer-Geindre, G. Reber, R. J. Fish, F. Boehlen, E. K. Kruithof, and P. de Moerloose. 2007. The role of TLR2 in the inflammatory activation of mouse fibroblasts by human antiphospholipid antibodies. Blood 109: 1507-1514.
56. Satta, N., E. K. Kruithof, C. Fickentscher, S. Dunoyer-Geindre, F. Boehlen, G. Reber, D. Burger, and P. de Moerloose. 2011. Toll-like receptor 2 mediates the activation of human monocytes and endothelial cells by antiphospholipid antibodies. Blood 117: 5523-5531.
57. Zhang, M., E. M. Alicot, I. Chiu, J. Li, N. Verna, T. Vorup-Jensen, B. Kessler, M. Shimaoka, R. Chan, D. Friend, et al. 2006. Identification of the target self-antigens in reperfusion injury. J. Exp. Med. 203: 141-152.
58. Fan, J., R. S. Frey, and A. B. Malik. 2003. TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase. J. Clin. Invest. 112: 1234-1243.
59. Ha, T., L. Liu, J. Kelley, R. Kao, D. Williams, and C. Li. 2011. Toll-like receptors: new players in myocardial ischemia/reperfusion injury. Antioxid. Redox Signal. 15: 1875-1893.
60. Mersmann, J., F. Iskandar, K. Latsch, K. Habeck, V. Sprunck, R. Zimmermann, R. R. Schumann, K. Zacharowski, and A. Koch. 2013. Attenuation of myocardial injury by HMGB1 blockade during ischemia/reperfusion is Toll-like receptor 2-dependent. Mediators Inflamm. 2013: 174168.
61. Yoshiya, K., P. H. Lapchak, T. H. Thai, L. Kannan, P. Rani, J. J. Dalle Lucca, and G. C. Tsokos. 2011. Depletion of gut commensal bacteria attenuates intestinal ischemia/reperfusion injury. Am. J. Physiol. Gastrointest. Liver Physiol. 301: G1020-G1030.